首页> 外文OA文献 >Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

【2h】

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

机译：黄体激素释放激素激动剂或经皮雌激素治疗的局部晚期和转移性前列腺癌患者的心血管结局：MRC PATCH 2期随机研究（PR09）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Langley Ruth E; Cafferty Fay H; Alhasso Abdulla A; Rosen Stuart D; Sundaram Subramanian Kanaga; Freeman Suzanne C; Pollock Philip; Jinks Rachel C; Godsland Ian F; Kockelbergh Roger; Clarke Noel W; Kynaston Howard G; Parmar Mahesh KB; Abel Paul D;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: The randomised, phase 2 MRC PATCH trial (PR09) [J] . LangleyR.E., CaffertyF.H., AlhassoA.A., The lancet oncology . 2013,第4期

机译：黄体激素释放激素激动剂或经皮雌激素治疗的局部晚期和转移性前列腺癌患者的心血管结局：MRC PATCH 2期随机研究（PR09）
2. Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. [J] . Langley RE, Godsland IF, Kynaston H, BJU international . 2008,第4期

机译：使用透皮雌激素蛋白的多元相二期试验早期激素数据作为局部晚期或转移前列腺癌患者的一线激素治疗。
3. Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status [J] . Giacchetti Sylvie, Hamy Anne-Sophie, Delaloge Suzette, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：Remagus 02试验的长期结果，在局部晚期乳腺癌患者的多中心随机分子II试验，根据HER2状态，用塞克昔布或曲妥珠单抗治疗Neoadjuvant化疗
4. Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer [C] . Diana C. Stripp, Rosemarie Mick, Timothy C. Zhu, Conference on optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy . 2004

机译：Matexafin-Lutetium介导的患者局部复发前列腺癌患者的术语I阶段试验
5. Risk for Cardiovascular Diseases in Prostate Cancer Patients Treated with Androgen Deprivation: A Population-based Cohort Study [D] . Jiang, Lei. 2018

机译：治疗雄激素剥夺治疗前列腺癌患者心血管疾病的风险：基于人群的群组研究
6. Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised phase 2 MRC PATCH trial (PR09) [O] . Ruth E Langley, Fay H Cafferty, Abdulla A Alhasso, -1

机译：黄体激素释放激素激动剂或经皮雌激素治疗的局部晚期转移性前列腺癌患者的心血管结局：MRC PATCH 2期随机研究（PR09）
7. Early hormonal data from a multicentre phase II trial using transdermal Oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic Prostate Cancer [O] . Langley, Ruth E., Godsland, Ian F., Kynaston, Howard, 2008

机译：早期激素数据来自多中心II期试验，使用透皮雌激素贴剂作为局部晚期或转移性前列腺癌患者的一线激素治疗

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

著录项

相似文献

相关主题

期刊订阅